INMUNE BIO INC. (INMB) Total liabilities 2017–2025
INMUNE BIO INC. (INMB) total liabilities at each fiscal year-end, per SEC filings.
$8.8MFY2025 · since FY2017: $309,717 → $8.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $8.8M | +18.2% |
| FY2024 | $7.5M | -60.4% |
| FY2023 | $18.9M | -13.0% |
| FY2022 | $21.7M | +10.0% |
| FY2021 | $19.7M | +936.8% |
| FY2020 | $1.9M | — |
| FY2018 | $823,766 | +166.0% |
| FY2017 | $309,717 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More INMB financial trends
INMB RevenueINMB Net incomeINMB Net marginINMB Gross profitINMB Gross marginINMB Operating incomeINMB Operating marginINMB Operating cash flowINMB Free cash flowINMB Capital expendituresINMB Return on equityINMB Stock buybacksINMB Dividends paidINMB Total assetsINMB Shareholders’ equityINMB overview →